Onco Wiki / Enfermedad

Carcinoma esofágico (escuámico + adeno)

Vista determinista de la entidad fuente YAML. La autoridad clínica sigue con los ID de fuente citados y estado de firma del revisor.

IDDIS-ESOPHAGEAL
TipoEnfermedad
Aliaces
CSC esofágica + adenocarcinomaCáncer esofágicoCarcinoma esofágicoКарцинома стравоходу (плоскоклітинна + аденокарцинома)
Situaciónreviewed 2026-04-26 | pending_clinical_signoff
EnfermedadesNinguna declarada
FuentesSRC-ESMO-ESOPHAGEAL-2024 SRC-NCCN-ESOPHAGEAL-2025

Informational support. All recommendations must be verified by a qualified oncologist. Engineering checks are not clinical validation or treatment approval.

Fuente YAML

icd_o_3_morphology8070/3
icd_o_3_topography["C15"]
icd_10C15
who_classificationWHO Digestive System Tumours 5th ed: Esophageal squamous cell carcinoma + esophageal adenocarcinoma

Capacidades

Notas

Scaffolded for Phase GI-1: 1 RF (high-grade dysphagia / aspiration — most common acute presentation), 1 indication (CROSS-style scaffold noting RT not modellable), 1 algorithm. Full histology-stratified algorithm (squamous: definitive CRT for unresectable, CROSS for resectable; adeno: FLOT preferred for resectable, CROSS alternative) + adjuvant nivolumab post-CROSS without pCR + metastatic biomarker- stratified ICI/chemo combos await ratification + clinical authoring. Histology branching is critical — squamous and adeno have largely parallel but partially divergent paradigms. Per-prompt allowance: one disease YAML covers both, with histology field on Indication applicability.

Utilizado por

Relevancia terapéutica

Algoritmos

Enfermedad

Indicación

Procedimientos

Cuestionarios

Señal de alerta

Fuentes